Alpha Blue Ocean Reaffirms its Commitment to the French Group Europlasma, the Auvergne-Rhône-Alpes Region and the Ministry of Economy for the Re-industrialization of the Forges de Gerzat
20.1.2022 10:00:00 EET | Business Wire | Press release
As a dedicated financial partner to Europlasma (Ticker: ALEUP FP) for the past four years, Alpha Blue Ocean, the family office founded by Pierre Vannineuse, has reaffirmed its support to the Landes-based Europlasma group as part of its new phase of development and re-industrialization with the essential contribution of the public authorities.
On January 10, Europlasma's management officially announced, collectively with the Ministry of the Economy, the Auvergne-Rhône-Alpes region and Clermont Auvergne Métropole, the reintroduction of manufacturing in France of high-pressure storage containers, a global innovation developed by Europlasma Environmental Technologies.
This project has been carried out at the Forges de Gerzat, a few months after the acquisition and re-launch of the Forges de Tarbes (Tarbes Industry). The project has been financed with the support of Alpha Blue Ocean, which has committed up to 25 million euros over the next seven years. This funding is based on pure long-term debt (subject to certain previous conditions, the definitive documentation is still under negotiation). This is in addition to the currently active convertible bond facility of 100 million euros executed in 2021 between Alpha Blue Ocean and Europlasma.
Pierre Vannineuse, Founder and CIO of Alpha Blue Ocean: "We have always believed in the possibilities offered by Europlasma's innovative and relatively unique technology. Four years ago, we would have thought it inconceivable that a French industry leader, a pioneer in its field, would close its doors once and for all. The recovery plan and redevelopment project were clear-cut and above all, the proposed management team was highly motivated and suited to the task at hand. Today, Europlasma is a leading force in French industry, having received the full support of the public authorities at all levels. It is a real source of immense pride to see what we have achieved in such a short period of time. As such, we would particularly like to thank Jérôme Garnache (Chairman of the Europlasma Group), Bruno Lemaire (Minister for the Economy, Finance and Recovery), Agnies Pannier-Runacher (Deputy Minister for Industry), Olivier Bianchi (President of Clermont Auvergne Métropole) and Laurent Wauquiez (President of the Regional Council of Auvergne-Rhône-Alpes) as well as their teams. We would also like to thank all those who have not been mentioned but who, through their work and determination, have actively participated in this success for France."
Jérôme Garnache, CEO of Europlasma: "This pan-European project would not have been possible without the resolve of Agnès Pannier-Runacher, Deputy Minister at the Minister for the Economy, the professionalism of the teams at the Ministry of the Economy and Finance, the commitment of Laurent Wauquiez, President of the Regional Council of Auvergne-Rhône-Alpes, Olivier Bianchi, President of Clermont Auvergne Métropole, and the support of Pierre Vannineuse and Hugo Pingray, co-founders of Alpha Blue Ocean."
The State and the Auvergne-Rhône-Alpes region will contribute 7.5 million euros. Additionally, the State will provide 15 million euros in debt financing. The region will offer support to Les Forges de Gerzat through its expertise in the field of training and professionalization. Finally, the Clermont Auvergne Métropole is committed to providing 34 million euros in financing for the land and the construction of an ergonomic industrial building.
Created in 2017, Alpha Blue Ocean is a pioneer and leading stakeholder in alternative finance in Europe and worldwide, particularly in the medical innovation sector. Over a four-year period, the group founded by Pierre Vannineuse has committed to over €1.5 bn in financial engagements, with 60% invested in the Health and Innovation Sectors.
For further information or to request an interview with an Alpha Blue Ocean executive, please contact the press office: pr@abo.co
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220119005215/en/
Contact information
Rajae Elantari - +971 58 539 7678 – r.elantari@abo.co
Samuel Botton – +33 6 84 79 99 61 – sbotton@stepconseil.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Alipay Launches Next-Generation AI Payment Infrastructure, Debuts AI Wallet and Token Pay to Power Agentic Economy26.5.2026 18:20:00 EEST | Press release
Alipay today introduced its full-stack AI payment solution to partners across industries, ranging from AI companies to traditional retailers, and debuted two new services — the world’s first AI Wallet and Token Pay — to support the agentic economy’s rapid growth. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260526337824/en/ Alipay Unveils Next-generation AI Payment Infrastructure This launch extends Alipay's next-generation AI payment infrastructure, building on its consumer-facing product Alipay AI Pay and its business-facing AI payment processing product. “While the essence of commerce remains unchanged in the age of AI, the emergence of AI agents is reshaping everything. Drawing on 22 years of technological expertise and commercial know-how, Alipay is building a new generation of AI payment services to accelerate the growth of the agentic commerce ecosystem,” said Cyril Han, CEO of Ant Group. AI Wallet: Giving Users Vis
Daiichi Sankyo Europe Reaffirms Commitment to Patient-Centred Care with Extensive Data Showcase at EAS Congress 202626.5.2026 18:00:00 EEST | Press release
Daiichi Sankyo Europe (DSE) is pleased to announce its extensive scientific presence at the European Atherosclerosis Society (EAS) Congress 2026. The presentation of 15 abstracts, comprising both clinical trial analyses and real-world evidence, underscores the company's sustained investment in cardiovascular health and its mission to care for every heartbeat. The 15-abstract showcase provides a comprehensive look at the role of bempedoic acid in lipid management. This includes post-hoc analyses in collaboration with Esperion Therapeutics from the Phase 3 CLEAR Outcomes trial exploring its impact on stroke and venous thromboembolism (VTE) incidence.5,6 There are also real-world findings from the MILOS registry, including a dedicated sub-analysis investigating the effectiveness of bempedoic acid across various background therapies.1,2,3,4 Results reinforce consistent effectiveness and safety profile of bempedoic acid across various EU countries and regardless of patients’ existing treatm
OpenRouter Raises $113 Million CapitalG-led Series B as Weekly Volume Explodes to 25T Tokens26.5.2026 16:15:00 EEST | Press release
OpenRouter, the AI model exchange, today announced a $113 million Series B led by Alphabet’s independent growth fund, CapitalG, with participation from investors including NVentures (NVIDIA’s venture capital arm), ServiceNow Ventures, MongoDB Ventures, Snowflake Ventures, Databricks Ventures, alongside existing investors including Andreessen Horowitz and Menlo Ventures. OpenRouter’s volume has surged to 25 trillion tokens per week (100 trillion tokens per month), representing a 5X increase from the 5 trillion tokens processed per week just six months ago. The explosion in token demand illustrates how quickly enterprises are deploying agents and scaling AI across multiple models and providers. OpenRouter’s infrastructure manages and optimizes inference and provides access to 400+ models across leading AI providers, including Anthropic, Google, OpenAI, xAI, and DeepSeek, among others. The platform is used by over 8 million global users, including AI-native startups and large enterprises,
Xsolla Expands Its Community Management Tools for Creators, Community Leaders, and Resellers26.5.2026 16:00:00 EEST | Press release
Xsolla, a leading global video game commerce company, today announced three simultaneous expansions of its community management tools and products. As the creator economy continues to reshape how games are discovered and the industry accelerates its shift toward direct-to-consumer commerce, Xsolla is building on its community management tools for creators, community leaders, and emerging markets, and will showcase them at TwitchCon Rotterdam later this month. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260526596720/en/ Graphic: Xsolla The games industry has never had a shortage of people who drive player acquisition, loyalty, and commerce; it's had a shortage of infrastructure that recognizes them. Creators stream it. Community leaders build a culture around it. Local resellers get it into the hands of players in markets traditional channels can't reach. Each operates at the center of how games are discovered, adopted, an
Biocytogen Launches AI-Powered RenSuper™ Platform and Industry-First Fully Automated Antibody Discovery Infrastructure26.5.2026 15:00:00 EEST | Press release
Biocytogen today announced the launch of RenSuper Workstation, a next-generation AI-powered antibody discovery platform providing off-the-shelf access to a large-scale, experimentally validated library of fully human therapeutic antibody sequences, together with the RenSuper High-Throughput Antibody Manufacturing Automation Center, a fully automated infrastructure designed to accelerate antibody validation and production. Built on Biocytogen’s proprietary RenMice® platforms, RenSuper establishes a closed-loop antibody discovery engine combining in vivo immune repertoires, AI-driven candidate selection, automated experimental validation, and scalable manufacturing infrastructure. The platform supports the discovery and development of monoclonal antibodies, bispecifics, multispecifics, antibody-drug conjugates (ADCs), VHHs, and other advanced therapeutic modalities, significantly reducing the time and risk associated with antibody discovery. RenSuper Workstation: AI-Powered One-Click Tar
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
